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Abstract
Semi-competing risks refer to the setting where primary scientific interest lies in estimation
and inference with respect to a non-terminal event, the occurrence of which is subject to
a terminal event. In this paper, we present the R package SemiCompRisks that pro-
vides functions to perform the analysis of independent/clustered semi-competing risks data
under the illness-death multi-state model. The package allows the user to choose the spec-
ification for model components from a range of options giving users substantial flexibility,
including: accelerated failure time or proportional hazards regression models; parametric or
non-parametric specifications for baseline survival functions; parametric or non-parametric
specifications for random effects distributions when the data are cluster-correlated; and, a
Markov or semi-Markov specification for terminal event following non-terminal event. While
estimation is mainly performed within the Bayesian paradigm, the package also provides
the maximum likelihood estimation for select parametric models. The package also includes
functions for univariate survival analysis as complementary analysis tools.
Keywords: illness-death models, multi-state models, semi-competing risks, survival analysis.
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1 Introduction
Semi-competing risks refer to the general setting where primary scientific interest lies in estima-
tion and inference with respect to a non-terminal event (e.g., disease diagnosis), the occurrence
of which is subject to a terminal event (e.g., death) (Fine et al., 2001; Jazic´ et al., 2016). When
there is a strong association between two event times, na¨ıve application of a univariate survival
model for non-terminal event time will result in overestimation of outcome rates as the analysis
treats the terminal event as an independent censoring mechanism (Haneuse and Lee, 2016). The
semi-competing risks analysis framework appropriately treats the terminal event as a competing
event and considers the dependence between non-terminal and terminal events as part of the
model specification.
Toward formally describing the structure of semi-competing risks data, let T1 and T2 denote
the times to the non-terminal and terminal events, respectively. From the modeling perspec-
tive, the focus in the semi-competing risks setting is to characterize the distribution T1 and its
potential relationship with the distribution of T2, i.e. the joint distribution of (T1, T2). For
example, from an initial state (e.g., transplantation), as time progresses, a subject could make a
transition into the non-terminal or terminal state (see Figure 1.a). In the case of a transition into
the non-terminal state, the subject could subsequently transition into the terminal state even
if these transitions cannot occur in the reverse order. The main disadvantage of the competing
risks framework (see Figure 1.b) to the study of non-terminal event is that it does not utilize the
information on the occurrence and timing of terminal event following the non-terminal event,
which could be used to understand the dependence between the two events.
The current literature for the analysis of semi-competing risks data is composed of three
approaches: methods that specify the dependence between non-terminal and terminal events
via a copula (Fine et al., 2001; Wang, 2003; Jiang et al., 2005; Ghosh, 2006; Peng and Fine,
2007; Lakhal et al., 2008; Hsieh et al., 2008; Fu et al., 2013); methods based on multi-state
models, specifically the so-called illness-death model (Liu et al., 2004; Putter et al., 2007; Ye
et al., 2007; Kneib and Hennerfeind, 2008; Zeng and Lin, 2009; Xu et al., 2010; Zeng et al.,
2012; Han et al., 2014; Zhang et al., 2014; Lee et al., 2015, 2016); and methods built upon the
principles of causal inference (Zhang and Rubin, 2003; Egleston et al., 2007; Tchetgen Tchetgen,
2014; Varadhan et al., 2014).
The SemiCompRisks package is designed to provide a comprehensive suite of functions for
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(a) Semi − competing risks.
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Figure 1: Graphical representation of (a) semi-competing risks and (b) competing risks.
the analysis of semi-competing risks data based on the illness-death model, together with, as a
complementary suite of tools, functions for the analysis of univariate time-to-event data. While
Bayesian methods are used for estimation and inference for all available models, maximum likeli-
hood estimation is also provided for select parametric models. Furthermore, SemiCompRisks
offers flexible parametric and non-parametric specifications for baseline survival functions and
cluster-specific random effects distributions under accelerated failure time and proportional haz-
ards models. The functionality of the package covers methods proposed in a series of recent
papers on the analysis of semi-competing risks data (Lee et al., 2015, 2016, 2017c).
The remainder of the paper is organized as follows. Section 2 summarizes existing R pack-
ages that provide methods for multi-state modeling, and explains the key contributions of the
SemiCompRisks package. Section 3 introduces an on-going study of stem cell transplantation
and provides a description of the data available in the package. Section 4 presents different spec-
ifications of models and estimation methods implemented in our package. Section 5 summarizes
the core components of the SemiCompRisks package, including datasets, functions for fitting
models, functions, the structure of output provided to analysts. Section 6 illustrates the usage
of the main functions in the package through three semi-competing risks analyses of the stem
cell transplantation data. Finally, Section 7 concludes with discussion and an overview of the
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extensions we are working on.
2 Other packages and their features
As we elaborate upon below, the illness-death model for semi-competing risks, that is the focus
on the SemiCompRisks package, is a special case of the broader class of multi-state models.
Currently, there are numerous R packages that permit estimation and inference for a multi-state
model and that could conceivably be used to analyze semi-competing risks data.
The mvna package computes the Nelson-Aalen estimator of the cumulative transition hazard
for arbitrary Markov multi-state models with right-censored and left-truncated data, but it does
not compute transition probability matrices (Allignol et al., 2008). The TPmsm implements
non-parametric and semi-parametric estimators for the transition probabilities in 3-state models,
including the Aalen-Johansen estimator and estimators that are consistent even without Markov
assumption or in case of dependent censoring (Arau´jo et al., 2014). The p3state.msm package
performs inference in an illness-death model (Meira-Machado and Roca-Pardin˜as, 2011). Its
main feature is the ability for obtaining non-Markov estimates for the transition probabilities.
The etm package calculates the empirical transition probability matrices and corresponding
variance estimates for any time-inhomogeneous multi-state model with finite state space and
data subject to right-censoring and left-truncation, but it does not account for the influence of
covariates (Allignol et al., 2011). The msm package is able to fit time-homogeneous Markov
models to panel count data and hidden Markov models in continuous time (Jackson, 2011).
The time-homogeneous Markov approach could be a particular case of the illness-death model,
where interval-censored data can be considered. The tdc.msm package may be used to fit
the time-dependent proportional hazards model and multi-state regression models in continuous
time, such as Cox Markov model, Cox semi-Markov model, homogeneous Markov model, non-
homogeneous piecewise model, and non-parametric Markov model (Meira-Machado et al., 2007).
The SemiMarkov package performs parametric (Weibull or exponentiated Weibull specifica-
tion) estimation in a homogeneous semi-Markov model (Kro´l and Saint-Pierre, 2015). Moreover,
the effects of covariates on the process evolution can be studied using a semi-parametric Cox
model for the distributions of sojourn times. The flexsurv package provides functions for
fitting and predicting from fully-parametric multi-state models with Markov or semi-Markov
specification (Jackson, 2016). In addition, the multi-state models implemented in flexsurv give
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the possibility to include interval-censoring and some of them also left-truncation. The msSurv
calculates non-parametric estimation of general multi-state models subject to independent right-
censoring and possibly left-truncation (Ferguson et al., 2012). This package also computes the
marginal state occupation probabilities along with the corresponding variance estimates, and
lower and upper confidence intervals. The mstate package can be applied to right-censored and
left-truncated data in semi-parametric or non-parametric multi-state models with or without
covariates and it may also be used to competing risk models (Wreede et al., 2011). Specifically
for Cox-type illness-death models to interval-censored data, we highlight the packages coxin-
terval (Boruvka and Cook, 2015) and SmoothHazard (Touraine et al., 2017), where the latter
also allows that the event times to be left-truncated. Finally, frailtypack package permits the
analysis of correlated data under select clusterings, as well as the analysis of left-truncated data,
through a focus on frailty models using penalized likelihood estimation or parametric estimation
(Rondeau et al., 2012).
While these packages collectively provide broad functionality, each of them is either non-
specific to semi-competing risks or only permits consideration of a narrow model specifications.
In developing the SemiCompRisks package, the goal was to provide a single package within
which a broad range of models and model specifications could be entertained. The frailtypack
package, for example, can also be used to analyze cluster-correlated semi-competing risks data
but it is restricted to the proportional hazards model with either patient-specific or cluster-
specific random effects but not both (Liquet et al., 2012). Furthermore, estimation/inference
is within the frequentist framework so that estimation of hospital-specific random effects, of
particular interest in health policy applications (Lee et al., 2016), together with the quantifi-
cation of uncertainty is incredibly challenging. This, however, is (relatively) easily achieved
through the functionality of SemiCompRisks package. Given the breadth of the function-
ality of the package, in addition to the usual help files, we have developed a series of model-
specific vignettes which can be accessed through the CRAN (Lee et al., 2017b) or R command
vignette("SemiCompRisks"), covering a total of 12 distinct model specifications.
3 CIBMTR data
The example dataset used throughout this paper was obtained from the Center for International
Blood and Marrow Transplant Research (CIBMTR), a collaboration between the National Mar-
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row Donor Program and the Medical College of Wisconsin representing a worldwide network
of transplant centers (Lee et al., 2017a). For illustrative purposes, we consider a hypothetical
study in which the goal is to investigate risk factors for grade III or IV acute graft-versus-host
disease (GVHD) among 9, 651 patients who underwent the first allogeneic hematopoietic cell
transplant (HCT) between January 1999 and December 2011.
As summarized in Table 1, after administratively censoring follow-up at 365 days post-
transplant, each patient can be categorized according to their observed outcome information
into four groups: (i) acute GVHD and death; (ii) acute GVHD and censored for death; (iii)
death without acute GVHD; and (iv) censored for both. Furthermore, for each patient, the
following covariates are available:gender (Male, Female); age (<10, 10-19, 20-29, 30-39, 40-
49, 50-59, 60+); disease type (AML, ALL, CML, MDS); disease stage (Early, Intermediate,
Advanced); and HLA compatibility (Identical sibling, 8/8, 7/8).
We note that due to confidentiality considerations the original study outcomes (time1, time2,
event1, event2: times and censoring indicators to the non-terminal and terminal events) are
not available in SemiCompRisks package. As such we provide the five original covariates
together with estimates of parameters from the analysis of CIBMTR data, so that one could
simulate semi-competing risks outcomes (see the simulation procedure in Appendix B). Based
on this, the data shown in Table 1 reflects simulated outcome data using 1405 as the seed.
4 The illness-death models for semi-competing risks data
We offer three flexible multi-state illness-death models for the analysis of semi-competing risks
data: accelerated failure time (AFT) models for independent data; proportional hazards regres-
sion (PHR) models for independent data; and PHR models for cluster-correlated data. These
models accommodate parametric or non-parametric specifications for baseline survival functions
as well as a Markov or semi-Markov assumptions for terminal event following non-terminal event.
4.1 AFT models for independent semi-competing risks data
In the AFT model specification, we directly model the connection between event times and
covariates (Wei, 1992). For the analysis of semi-competing risks data, we consider the following
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Outcome category (%)
Both
acute GVHD
& death
Acute GVHD
& censored
for death
Death
without
acute GVHD
Censored
for bothN %
Total subjects 9,651 100.0 9.5 8.9 28.8 52.8
Gender
Male 5,366 55.6 9.7 9.5 28.1 52.7
Female 4,285 44.4 9.1 8.3 29.7 52.9
Age, years
<10 653 6.8 5.0 11.9 23.4 59.7
10-19 1,162 12.0 8.0 11.4 24.0 56.6
20-29 1,572 16.3 9.7 9.9 27.4 53.0
30-39 1,581 16.4 9.8 10.7 28.5 51.0
40-49 2,095 21.7 11.0 9.6 29.7 49.7
50-59 2,008 20.8 9.8 5.1 32.3 52.8
60+ 580 6.0 9.9 4.8 33.1 52.2
Disease type
AML 4,919 51.0 8.2 8.0 30.3 53.5
ALL 2,071 21.5 9.9 9.0 29.3 51.8
CML 1,525 15.8 12.1 11.3 22.2 54.4
MDS 1,136 11.8 11.0 10.0 30.0 49.0
Disease status
Early 4,873 50.5 8.4 11.0 23.6 57.0
Intermediate 2,316 24.0 9.7 8.5 30.1 51.7
Advanced 2,462 25.5 11.5 5.4 37.7 45.4
HLA compatibility
Identical sibling 3,941 40.8 7.4 8.5 26.3 57.8
8/8 4,100 42.5 10.5 9.7 30.3 49.5
7/8 1,610 16.7 12.2 8.1 30.9 48.8
Table 1: Covariate and simulated outcome information for 9,651 patients who underwent the
first HCT between 1999-2011 with administrative censoring at 365 days.
AFT model specifications under the illness-death modeling framework (Lee et al., 2017c):
log(Ti1) = x
>
i1β1 + γi + i1, Ti1 > 0, (1)
log(Ti2) = x
>
i2β2 + γi + i2, Ti2 > 0, (2)
log(Ti2 − Ti1) = x>i3β3 + γi + i3, Ti2 > Ti1, (3)
where Ti1 and Ti2 denote the times to the non-terminal and terminal events, respectively, from
subject i = 1, . . . , n, xig is a vector of transition-specific covariates, βg is a corresponding vector
of transition-specific regression parameters, and ig is a transition-specific random variable whose
distribution determines that of the corresponding transition time, g ∈ {1, 2, 3}. Finally, in
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each of (1)-(3), γi is a study subject-specific random effect that induces positive dependence
between the two event times. We assume that γi follows a Normal(0, θ) distribution and adopt
a conjugate inverse Gamma distribution, denoted by IG(a(θ), b(θ)) for the variance component
θ. For regression parameters βg, we adopt non-informative flat prior on the real line.
From models (1)-(3), we can adopt either a fully parametric or a semi-parametric approach
depending on the specification of the distributions for i1, i2, i3. We build a parametric
modeling based on the log-Normal formulation, where ig follows a Normal(µg, σ
2
g) distribution.
We adopt non-informative flat priors on the real line for µg and independent IG(a
(σ)
g , b
(σ)
g ) for
σ2g . As an alternative, a semi-parametric framework can be considered by adopting independent
non-parametric Dirichlet process mixtures (DPM) of Mg Normal(µgr, σ
2
gr) distributions, r ∈
{1, . . . ,Mg}, for each ig. Following convention in the literature, we refer to each component
Normal distribution as being specific to some “class” (Neal, 2000). Since the class-specific
(µgr, σ
2
gr) are unknown, they are assumed to be draws from a so-called the centering distribution.
Specifically, we take a Normal distribution centered at µg0 with a variance σ
2
g0 for µgr and an
IG(a
(σgr)
g , b
(σgr)
g ) for σ2gr. Furthermore, since the “true” class membership for any given study
subject is unknown, we let pgr denote the probability of belonging to the rth class for transition g
and pg = (pg1, . . . , pgMg)
> the collection of such probabilities. In the absence of prior knowledge
regarding the distribution of class memberships for the n subjects across the Mg classes, pg is
assumed to follow a conjugate symmetric Dirichlet(τg/Mg, . . . , τg/Mg) distribution, where τg is
referred to as the precision parameter (for more details, see Lee et al., 2017c).
Our AFT modeling framework can also handle interval-censored and/or left-truncated semi-
competing risks data. Suppose that subject i was observed at follow-up times {ci1, . . . , cimi} and
let c∗i and Li denote the time to the end of study (or administrative right-censoring) and the
time at study entry (i.e., the left-truncation time), respectively. Considering interval-censoring
for both events, Ti1 and Ti2, for i = 1, . . . , n, satisfy cij ≤ Ti1 < cij+1 for some j and cik ≤
Ti2 < cik+1 for some k, respectively. Therefore, the observed outcome information for interval-
censored and left-truncated semi-competing risks data for the subject i can be represented by
{Li, cij , cij+1, cik, cik+1}.
4.2 PHR models for independent semi-competing risks data
We consider an illness-death multi-state model with proportional hazards assumptions char-
acterized by three hazard functions (see Figure 1.a) that govern the rates at which subjects
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transition between the states: a cause-specific hazard for non-terminal event, h1(ti1); a cause-
specific hazard for terminal event, h2(ti2); and a hazard for terminal event conditional on a time
for non-terminal event, h3(ti2 | ti1). We consider the following specification for hazard functions
(Xu et al., 2010; Lee et al., 2015):
h1(ti1 | γi,xi1) = γi h01(ti1) exp(x>i1β1), ti1 > 0, (4)
h2(ti2 | γi,xi2) = γi h02(ti2) exp(x>i2β2), ti2 > 0, (5)
h3(ti2 | ti1, γi,xi3) = γi h03(z(ti1, ti2)) exp(x>i3β3), ti2 > ti1, (6)
where h0g is an unspecified baseline hazard function and βg is a vector of log-hazard ratio
regression parameters associated with the covariates xig. Finally, in each of (4)-(6), γi is a
study subject-specific shared frailty following a Gamma(θ−1, θ−1) distribution, parametrized so
that E [γi] = 1 and V [γi] = θ. The model (6) is referred to as being Markov or semi-Markov
depending on whether we assume z(ti1, ti2) = ti2 or z(ti1, ti2) = ti2 − ti1, respectively.
The Bayesian approach for models (4)-(6) requires the specification of prior distributions
for unknown parameters. For the regression parameters βg, we adopt a non-informative flat
prior distribution on the real line. For the variance in the subject-specific frailties, θ, we adopt
a Gamma(a(θ), b(θ)) for the precision θ−1. For the parametric specification for baseline hazard
functions, we consider a Weibull model: h0g(t) = αg κg t
αg−1. We assign a Gamma(a(α)g , b
(α)
g ) for
αg and a Gamma(c
(κ)
g , d
(κ)
g ) for κg. As an alternative, a non-parametric piecewise exponential
model (PEM) is considered for baseline hazard functions based on taking each of the log-baseline
hazard functions to be a flexible mixture of piecewise constant function. Let sg,max denote the
largest observed event time for each transition and construct a finite partition of the time axis,
0 = sg,0 < sg,1 < sg,2 < . . . < sg,Kg+1 = sg,max. Letting λg = (λg,1, . . . , λg,Kg , λg,Kg+1)
>
denote the heights of the log-baseline hazard function on the disjoint intervals based on the time
splits sg = (sg,1, . . . , sg,Kg+1)
>, we assume that λg follows a multivariate Normal distribution
(MVN), MVN(µλg1, σ
2
λg
Σλg), where µλg is the overall mean, σ
2
λg
represents a common variance
component for the Kg + 1 elements, and Σλg specifies the covariance structure these elements.
We adopt a flat prior on the real line for µλg and a conjugate Gamma(a
(σ)
g , b
(σ)
g ) distribution for
the precision σ−2λg . In order to relax the assumption of fixed partition of the time scales, we adopt
a Poisson(α
(K)
g ) prior for the number of splits, Kg, and conditioned on the number of splits, we
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consider locations, sg, to be a priori distributed as the even-numbered order statistics:
pi(sg | Kg) ∝ (2Kg + 1)!
∏Kg+1
k=1 (sg,k − sg,k−1)
(sg,Kg+1)
2Kg+1
. (7)
Note that the prior distributions of Kg and sg jointly form a time-homogeneous Poisson process
prior for the partition (Kg, sg). For more details, see Lee et al. (2015).
4.3 PHR models for cluster-correlated semi-competing risks data
Lee et al. (2016) proposed hierarchical models that accommodate correlation in the joint distri-
bution of the non-terminal and terminal events across patients for the setting where patients are
clustered within hospitals. The hierarchical models for cluster-correlated semi-competing risks
data build upon the illness-death model given in (4)-(6). Let Tji1 and Tji2 denote the times
to the non-terminal and terminal events for the ith subject in the jth cluster, respectively, for
i = 1, . . . , nj and j = 1, . . . , J . The general modeling specification is given by:
h1(tji1 | γji,xji1, Vj1) = γji h01(tji2) exp(x>ji1β1 + Vj1), tji1 > 0, (8)
h2(tji2 | γji,xji2, Vj2) = γji h02(tji2) exp(x>ji2β2 + Vj2), tji2 > 0, (9)
h3(tji2 | tji1, γji,xji3, Vj3) = γji h03(z(tji1, tji2)) exp(x>ji3β3 + Vj3), tji2 > tji1, (10)
where h0g is an unspecified baseline hazard function and βg is a vector of log-hazard ratio
regression parameters associated with the covariates xjig. A study subject-specific shared frailty
γji is assumed to follow a Gamma(θ
−1, θ−1) distribution and Vj = (Vj1, Vj2, Vj3)> is a vector of
cluster-specific random effects, each specific to one of the three possible transitions.
From a Bayesian perspective for models (8)-(10), we can adopt either a parametric Weibull
or non-parametric PEM specification for baseline hazard functions h0g with their respective
configurations of prior distributions analogous to those outlined in Section 4.2. For the para-
metric specification of cluster-specific random effects, we assume that Vj follows MVN3(0,ΣV )
distribution. We adopt a conjugate inverse-Wishart(Ψv, ρv) prior for the variance-covariance
matrix ΣV . For the non-parametric specification, we adopt a DPM of MVN distributions with
a centering distribution, G0, and a precision parameter, τ . Here we take G0 to be a multivariate
Normal/inverse-Wishart (NIW) distribution for which the probability density function can be
expressed as the product:
fNIW(µ,Σ | Ψ0, ρ0) = fMVN(µ | 0,Σ)× finverse-Wishart(Σ | Ψ0, ρ0), (11)
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where Ψ0 and ρ0 are the hyperparameters of fNIW(·). We assign a Gamma(aτ , bτ ) prior distri-
bution for τ . Finally, for βg and θ, we adopt the same priors as those adopted for the model in
Section 4.2. For more details, see Lee et al. (2016).
4.4 Estimation and inference
Bayesian estimation and inference is available for all models in the SemiCompRisks. Addi-
tionally, one may also choose to use maximum likelihood estimation for the parametric Weibull
PHR model described in Section 4.2.
To perform Bayesian estimation and inference, we use a random scan Gibbs sampling algo-
rithm to generate samples from the full posterior distribution. Depending on the complexity of
the model adopted, the Markov chain Monte Carlo (MCMC) scheme may also include additional
strategies, such as Metropolis-Hastings and reversible jump MCMC (Metropolis-Hastings-Green)
steps. Specific details of each implementation can be seen in the online supplemental materials
of Lee et al. (2015, 2016, 2017c).
5 Package description
The SemiCompRisks package contains three key functions, FreqID HReg, BayesID HReg and
BayesID AFT, focused on models for semi-competing risks data as well as the analogous univariate
survival models, FreqSurv HReg, BayesSurv HReg and BayesSurv AFT. It also provides two
auxiliary functions, initiate.startValues HReg and initiate.startValues AFT, that can
be used to generate initial values for Bayesian estimation; simID and simSurv functions for
simulating semi-competing risks and univariate survival data, respectively; five covariates and
parameter estimates from CIBMTR data; and the BMT dataset referring to 137 bone marrow
transplant patients.
5.1 Summary of functionality
Table 2 shows the modeling options implemented in the SemiCompRisks package for both
semi-competing risks and univariate analysis. Specifically, we categorize the approaches based on
the analysis type (semi-competing risks or univariate), the survival model (AFT or PHR), data
type (independent or clustered), accommodation to left-truncation and/or interval-censoring in
addition to right-censoring, and also statistical paradigms (frequentist or Bayesian).
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Analysis Model Data type L-T and/or I-C Statistical paradigm
AFT
Independent
No B
Yes B
Clustered
No x
Semi-competing Yes x
risks
PHR
Independent
No B & F
Yes x
Clustered
No B
Yes x
Univariate
AFT
Independent
No B
Yes B
Clustered
No x
Yes x
PHR
Independent
No B & F
Yes x
Clustered
No B
Yes x
L-T: left-truncation; I-C: interval-censoring; B: Bayesian; F: frequentist; x: not available
Table 2: Models implemented in the SemiCompRisks package.
The full description of functionality of the SemiCompRisks package can be accessed
through the R command help("SemiCompRisks") or vignette("SemiCompRisks") which pro-
vides in detail the specification of all models implemented in the package. Below we describe
the input data format and some crucial arguments for defining and fitting a model for semi-
competing risks data using the SemiCompRisks package.
5.1.1 Model specification
From a semi-competing risks dataset, we jointly define the outcomes and covariates in a Formula
object. Here we use the simCIBMTR dataset, obtained from the simulation procedure presented
in Appendix B:
R> form <- Formula(time1 + event1 | time2 + event2 ~ dTypeALL + dTypeCML +
+ dTypeMDS + sexP | dTypeALL + dTypeCML + dTypeMDS | dTypeALL +
+ dTypeCML + dTypeMDS)
The outcomes time1, time2, event1 and event2 denote the times and censoring indicators
to the non-terminal and terminal events, respectively, and the covariates of each hazard function
12
are separated by | (vertical bar).
The specification of the Formula object varies slightly if the semi-competing risks model
accommodates left-truncated and/or interval-censored data (see vignette documentation Lee
et al. (2017b)).
5.1.2 Critical arguments
Most functions for semi-competing risks analysis in the SemiCompRisks package take common
arguments. These arguments and their descriptions are shown as follows:
• id: a vector of cluster information for n subjects, where cluster membership corresponds
to one of the positive integers 1, . . . , J .
• model: a character vector that specifies the type of components in a model. It can have
up to three elements depending on the model specification. The first element is for the
assumption on h3: “semi-Markov” or “Markov”. The second element is for the specification
of baseline hazard functions for PHR models - “Weibull” or “PEM” - or baseline survival
distribution for AFT models - “LN” (log-Normal) or “DPM”. The third element needs to
be set only for clustered semi-competing risks data and is for the specification of cluster-
specific random effects distribution: “MVN” or “DPM”.
• hyperParams: a list containing vectors for hyperparameter values in hierarchical models.
• startValues: a list containing vectors of starting values for model parameters.
• mcmcParams: a list containing variables required for MCMC sampling.
Hyperparameter values, starting values for model parameters, and MCMC arguments depend
on the specified Bayesian model and the assigned prior distributions. For a list of illustrations,
see vignette documentation Lee et al. (2017b).
5.2 FreqID HReg
The function FreqID HReg fits Weibull PHR models for independent semi-competing risks data,
as in (4)-(6), based on maximum likelihood estimation. Its default structure is given by
FreqID_HReg(Formula, data, model="semi-Markov", frailty=TRUE),
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where Formula represents the outcomes and the linear predictors jointly, as presented in Sec-
tion 5.1; data is a data frame containing the variables named in Formula; model is one of the
critical arguments of the SemiCompRisks package (see Section 5.1), in which it specifies the
type of model based on the assumption on h3(ti2 | ti1, ·) in (6). Here, model can be “Markov”
or “semi-Markov”. Finally, frailty is a logical value (TRUE or FALSE) to determine whether to
include the subject-specific shared frailty term γ into the illness-death model.
5.3 BayesID HReg
The function BayesID HReg fits parametric and semi-parametric PHR models for independent
or cluster-correlated semi-competing risks data, as in (4)-(6) or (8)-(10), based on Bayesian
inference. Its default structure is given by
BayesID_HReg(Formula, data, id=NULL, model=c("semi-Markov","Weibull"),
hyperParams, startValues, mcmcParams, path=NULL)
Formula and data are analogous to the previous case; id, model, hyperParams, startValues,
and mcmcParams are all critical arguments of the SemiCompRisks package (see Section 5.1),
where id indicates the cluster that each subject belongs to (for independent data, id=NULL);
model allows us to specify either “Markov” or “semi-Markov” assumption, whether the priors for
baseline hazard functions are parametric (“Weibull”) or non-parametric (“PEM”), and whether
the cluster-specific random effects distribution is parametric (“MVN”) or non-parametric (“DPM”).
The third element of model is only required for models for clustered-correlated data given in
(8)-(10).
The hyperParams argument defines all model hyperparameters: theta (a numeric vector
for hyperparameters, a(θ) and b(θ), in the prior of subject-specific frailty variance component),
WB (a list containing numeric vectors for Weibull hyperparameters (a
(α)
g , b
(α)
g ) and (c
(κ)
g , d
(κ)
g )
for g ∈ {1, 2, 3}: WB.ab1, WB.ab2, WB.ab3, WB.cd1, WB.cd2, WB.cd3), PEM (a list containing
numeric vectors for PEM hyperparameters (a
(σ)
g , b
(σ)
g ), and α
(K)
g for g ∈ {1, 2, 3}: PEM.ab1,
PEM.ab2, PEM.ab3, PEM.alpha1, PEM.alpha2, PEM.alpha3); and for the analysis of clustered
semi-competing risks data, additional components are required: MVN (a list containing numeric
vectors for MVN hyperparameters Ψv and ρv: Psi v, rho v), DPM (a list containing numeric
vectors for DPM hyperparameters Ψ0, ρ0, aτ , and bτ : Psi0, rho0, aTau, bTau).
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The startValues argument specifies initial values for model parameters. This specification
can be done manually or through the auxiliary function initiate.startValues HReg. The
mcmcParams argument sets the information for MCMC sampling: run (a list containing numeric
values for setting for the overall run: numReps, total number of scans; thin, extent of thinning;
burninPerc, the proportion of burn-in), storage (a list containing numeric values for storing
posterior samples for subject- and cluster-specific random effects: nGam save, the number of
γ to be stored; storeV, a vector of three logical values to determine whether all the posterior
samples of Vj , for j = 1, . . . , J are to be stored), tuning (a list containing numeric values rele-
vant to tuning parameters for specific updates in Metropolis-Hastings-Green (MHG) algorithm:
mhProp theta var, the variance of proposal density for θ; mhProp Vg var, the variance of pro-
posal density for Vj in DPM models; mhProp alphag var, the variance of proposal density for αg
in Weibull models; Cg, a vector of three proportions that determine the sum of probabilities of
choosing the birth and the death moves in PEM models (the sum of the three elements should
not exceed 0.6); delPertg, the perturbation parameters in the birth update in PEM models
(the values must be between 0 and 0.5); rj.scheme: if rj.scheme=1, the birth update will
draw the proposal time split from 1:sg max and if rj.scheme=2, the birth update will draw the
proposal time split from uniquely ordered failure times in the data. For PEM models, additional
components are required: Kg max, the maximum number of splits allowed at each iteration in
MHG algorithm for PEM models; time lambda1, time lambda2, time lambda3, time points at
which the posterior distribution of log-hazard functions are calculated. Finally, path indicates
the name of directory where the results are saved. For more details and examples, see Lee et al.
(2017b).
5.4 BayesID AFT
The function BayesID AFT fits parametric and semi-parametric AFT models for independent
semi-competing risks data, given in (1)-(3), based on Bayesian inference. Its default structure
is given by
BayesID_AFT(Formula, data, model="LN", hyperParams, startValues, mcmcParams,
path=NULL),
where data, startValues (auxiliary function initiate.startValues AFT), and path are anal-
ogous to functions described in previous sections. Here, Formula has a different structure
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of outcomes, since the AFT model accommodates more complex censoring, such as interval-
censoring and/or left-truncation (see Section 4.1). It takes the generic form Formula(LT | y1L
+ y1U | y2L + y2U cov1 | cov2 | cov3), where LT represents the left-truncation time,
(y1L, y1U) and (y2L, y2U) are the interval-censored times to the non-terminal and terminal
events, respectively, and cov1, cov2 and cov3 are covariates of each linear regression. The
model argument specifies whether the baseline survival distribution is parametric (“LN”) or non-
parametric (“DPM”). The hyperParams argument defines all model hyperparameters: theta is
for hyperparameters (a(θ) and b(θ))); LN is a list containing numeric vectors, LN.ab1, LN.ab2,
LN.ab3, for log-Normal hyperparameters (a
(σ)
g , b
(σ)
g ) with g ∈ {1, 2, 3}; DPM is a list containing
numeric vectors, DPM.mu1, DPM.mu2, DPM.mu3, DPM.sigSq1, DPM.sigSq2, DPM.sigSq3, DPM.ab1,
DPM.ab2, DPM.ab3, Tau.ab1, Tau.ab2, Tau.ab3 for DPM hyperparameters (µg0, σ
2
g0), (a
(σgr)
g ,
b
(σgr)
g ), and τg with g ∈ {1, 2, 3}. The mcmcParams argument sets the information for MCMC
sampling: run (see Section 5.3), storage (nGam save; nY1 save, the number of y1 to be stored;
nY2 save, the number of y2 to be stored; nY1.NA save, the number of y1==NA to be stored),
tuning (betag.prop.var, the variance of proposal density for βg; mug.prop.var, the vari-
ance of proposal density for µg; zetag.prop.var, the variance of proposal density for 1/σ
2
g ;
gamma.prop.var, the variance of proposal density for γ).
5.5 Univariate survival data analysis
The functions FreqSurv HReg, BayesSurv HReg and BayesSurv AFT provide the same flexibility
as functions FreqID HReg, BayesID HReg and BayesID AFT, respectively, but in a univariate
context (i.e., a single outcome).
The function FreqSurv HReg fits a Weibull PHR model based on maximum likelihood esti-
mation. This model is described by:
h(ti | xi) = ακ tα−1i exp(x>i β), ti > 0. (12)
The function BayesSurv HReg implements Bayesian PHR models given by:
h(tji | xji) = h0(tji) exp(x>jiβ + Vj), ti > 0, (13)
We can adopt either a parametric Weibull or a non-parametric PEM specification for h0. Cluster-
specific random effects Vj , j = 1, . . . , J , can be assumed to follow a parametric Normal distri-
bution or a non-parametric DPM of Normal distributions.
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Finally, the function BayesSurv AFT implements Bayesian AFT models expressed by:
log(Ti) = x
>
i β + i, Ti > 0, (14)
where we can adopt either a fully parametric log-Normal or a non-parametric DPM specification
for i .
5.6 Summary output
The functions presented in Sections 5.2, 5.3 and 5.4 return objects of classes Freq HReg, Bayes HReg
and Bayes AFT, respectively. Each of these objects represents results from its respective semi-
competing risks analysis. These results can be visualized using several R methods, such as
print, summary, predict, plot, coef, and vcov.
The function print shows the estimated parameters and, in the Bayesian case, also the
MCMC description (number of chains, scans, thinning, and burn-in) and the potential scale
reduction factor (PSRF) convergence diagnostic for each model parameter (Gelman and Rubin,
1992; Brooks and Gelman, 1998). If the PSRF is close to 1, a group of chains have mixed
well and have converged to a stable distribution. The function summary presents the regression
parameters in exponential format (hazard ratios) and the estimated baseline hazard function
components.
Functions predict and plot complement each other. The former uses the fitted model to
predict an output of interest (survival or hazard) at a given time interval from new covari-
ates. From the object created by predict, plot displays survival (plot.est="Surv") or hazard
(plot.est="Haz") functions with their respective 95% confidence/credibility intervals.
Additionally, SemiCompRisks provides the standard functions coef (model coefficients)
and vcov (variance-covariance matrix for a fitted frequentist model). For examples with more
details, see Lee et al. (2017b).
5.7 Simulation of semi-competing risks data
The function simID simulates semi-competing risks outcomes from independent or cluster-
correlated data (for more details of the simulation algorithm, see Appendix A). The simulation
is based on a semi-Markov Weibull PHR modeling and, in the case of the cluster-correlated ap-
proach, the cluster-specific random effects follow a MVN distribution. We provide a simulation
example of independent semi-competing risks data in Appendix B.
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Analogously, the function simSurv simulates univariate independent/cluster-correlated sur-
vival data under a Weibull PHR model with cluster-specific random effects following a Normal
distribution.
5.8 Datasets
CIBMTR data. It is composed of 5 covariates that come from a study of acute GVHD with
9, 651 patients who underwent the first allogeneic hematopoietic cell transplant between January
1999 and December 2011 (see Section 3).
BMT data. It refers to a well-known study of bone marrow transplantation for acute leukemia
(Klein and Moeschberger, 2003). This data frame contains 137 patients with 22 variables and
its description can be viewed from the R command help(BMT).
6 Illustration: Stem Cell Transplantation data
In our first example we employ the modeling (4)-(6) for independent data, semi-Markov assump-
tion and Weibull baseline hazards. Here, Formula (form) is defined as in Section 5.1. We fit
the model using the function FreqID HReg, described in Section 5.2, and visualize the results
through the function summary:
6.1 Frequentist analysis
6.1.1 Independent semi-Markov PHR model with Weibull baseline hazards
In our first example we employ the modeling (4)-(6) for independent data, semi-Markov assump-
tion and Weibull baseline hazards. Here, Formula (form) is defined as in Section 5.1. We fit
the model using the function FreqID HReg, described in Section 5.2, and visualize the results
through the function summary:
R> fitFreqPHR <- FreqID_HReg(form, data=simCIBMTR, model="semi-Markov")
R> summary(fitFreqPHR)
Analysis of independent semi-competing risks data
semi-Markov assumption for h3
Hazard ratios:
beta1 LL UL beta2 LL UL beta3 LL UL
dTypeALL 1.49 1.20 1.8 1.37 1.09 1.7 0.99 0.78 1.3
dTypeCML 1.78 1.41 2.3 0.83 0.64 1.1 1.30 0.99 1.7
dTypeMDS 1.64 1.26 2.1 1.39 1.04 1.9 1.49 1.09 2.0
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sexP 0.89 0.79 1.0 NA NA NA NA NA NA
Variance of frailties:
Estimate LL UL
theta 7.8 7.3 8.4
Baseline hazard function components:
h1-PM LL UL h2-PM LL UL h3-PM LL UL
Weibull: log-kappa -6.14 -6.4 -5.90 -11.33 -11.74 -10.93 -6.873 -7.189 -6.557
Weibull: log-alpha 0.15 0.1 0.21 0.86 0.82 0.91 0.022 -0.033 0.077
As shown in Section 5.6, summary provides estimates of all model parameters. Using the
auxiliary functions predict (default option x1new=x2new=x3new=NULL which corresponds to
the baseline specification) and plot, we can graphically visualize the results:
R> pred <- predict(fitFreqPHR, time=seq(0,365,1), tseq=seq(from=0,to=365,by=30))
R> plot(pred, plot.est="Surv")
R> plot(pred, plot.est="Haz")
Figure 2 displays estimated baseline survival and hazard functions (solid line) with their
corresponding 95% confidence intervals (dotted line).
6.2 Bayesian analysis
6.2.1 Independent semi-Markov PHR model with PEM baseline hazards
Our second example is also based on the models (4)-(6) adopting a semi-Markov assumption
for h3, but now we use the non-parametric PEM specification for baseline hazard functions.
Again, Formula is defined as in Section 5.1. Here we employ the Bayesian estimation by means
of the function BayesID HReg, described in Section 5.3. The first step is to specify initial
values for model parameters through the startValues argument using the auxiliary function
initiate.startValues HReg:
R> startValues <- initiate.startValues_HReg(form, data=simCIBMTR,
+ model=c("semi-Markov","PEM"), nChain=3)
The nChain argument indicates the number of Markov chains that will be used in the MCMC
algorithm. Next step is to define all model hyperparameters using the hyperParams argument:
R> hyperParams <- list(theta=c(0.5,0.05), PEM=list(PEM.ab1=c(0.5,0.05),
+ PEM.ab2=c(0.5,0.05), PEM.ab3=c(0.5,0.05), PEM.alpha1=10,
+ PEM.alpha2=10, PEM.alpha3=10))
To recall what prior distributions are related to these hyperparameters, see Section 4.3. Now
we set the MCMC configuration for the mcmcParams argument, more specifically defining the
overall run, storage, and tuning parameters for specific updates:
R> sg_max <- c(max(simCIBMTR$time1[simCIBMTR$event1==1]),
+ max(simCIBMTR$time2[simCIBMTR$event1==0 & simCIBMTR$event2==1]),
+ max(simCIBMTR$time2[simCIBMTR$event1==1 & simCIBMTR$event2==1]))
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 Figure 2: Estimated baseline survival (top) and hazard (bottom) functions from the above
analysis.
R> mcmcParams <- list(run=list(numReps=5e6, thin=1e3, burninPerc=0.5),
+ storage=list(nGam_save=0, storeV=rep(FALSE,3)),
+ tuning=list(mhProp_theta_var=0.05, Cg=rep(0.2,3), delPertg=rep(0.5,3),
+ rj.scheme=1, Kg_max=rep(50,3), sg_max=sg_max, time_lambda1=seq(1,sg_max[1],1),
+ time_lambda2=seq(1,sg_max[2],1), time_lambda3=seq(1,sg_max[3],1)))
As shown above, we set sg max to the largest observed failure times for g ∈ {1, 2, 3}. For
more details of each item of mcmcParams, see Section 5.3.
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Given this setup, we fit the PHR model using the function BayesID HReg:
R> fitBayesPHR <- BayesID_HReg(form, data=simCIBMTR, model=c("semi-Markov","PEM"),
+ startValues=startValues, hyperParams=hyperParams, mcmcParams=mcmcParams)
We note that, depending on the complexity of the model specification (e.g. if PEM baseline
hazards are adopted) and the size of the dataset, despite the functions having been written in C
and compiled for R, the MCMC scheme may require a large number of MCMC scans to ensure
convergence. As such, some models may take a relatively long time to converge. The example we
present below, for example, took 45 hours on a Windows laptop with an Intel(R) Core(TM) i5-
3337U 1.80GHz processor, 2 cores, 4 logical processors, 4GB of RAM and 3MB of cache memory
to cycle through the 6 millions scans for 3 chains. In lieu of attempting to reproduce the exact
results we present here, while readers are of course free to do, Appendix C provides the code
for this same semi-competing risks model and its respective posterior summary, but based on a
reduced number of scans of the MCMC scheme (specifically 50,000 scans for 3 chains). Based
on the full set of scans, the print method for object returned by BayesID HReg, yields:
R> print(fitBayesPHR, digits=2)
Analysis of independent semi-competing risks data
semi-Markov assumption for h3
Number of chains: 3
Number of scans: 5e+06
Thinning: 1000
Percentage of burnin: 50%
######
Potential Scale Reduction Factor
Variance of frailties, theta:
1
Regression coefficients:
beta1 beta2 beta3
dTypeALL 1 1 1
dTypeCML 1 1 1
dTypeMDS 1 1 1
sexP 1 NA NA
Baseline hazard function components:
lambda1: summary statistics
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.00 1.00 1.00 1.00 1.00 1.01
lambda2: summary statistics
Min. 1st Qu. Median Mean 3rd Qu. Max.
21
1.00 1.00 1.00 1.00 1.00 1.01
lambda3: summary statistics
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.00 1.00 1.00 1.00 1.01 1.01
h1 h2 h3
mu 1 1 1
sigmaSq 1 1 1
K 1 1 1
...
Note that all parameters obtained PSRF close to 1, indicating that the chains have converged
well (see Section 5.6). Convergence can also be assessed graphically through a trace plot:
R> plot(fitBayesPHR$chain1$theta.p, type="l", col="red",
+ xlab="iteration", ylab=expression(theta))
R> lines(fitBayesPHR$chain2$theta.p, type="l", col="green")
R> lines(fitBayesPHR$chain3$theta.p, type="l", col="blue")
0 500 1000 1500 2000 2500
6.
0
6.
5
7.
0
7.
5
iteration
θ
Figure 3: Convergence diagnostic via trace plot of multiple chains.
Figure 3 shows convergence diagnostic for θ (subject-specific frailty variance component),
where the three chains have mixed and converged to a stable distribution. Any other model
parameter could be similarly evaluated. Analogous to the frequentist example, we can also
visualize the results through the function summary:
R> summary(fitBayesPHR)
22
Analysis of independent semi-competing risks data
semi-Markov assumption for h3
#####
Hazard ratios:
exp(beta1) LL UL exp(beta2) LL UL exp(beta3) LL UL
dTypeALL 1.45 1.18 1.8 1.32 1.07 1.6 0.99 0.77 1.3
dTypeCML 1.73 1.39 2.2 0.81 0.63 1.0 1.26 0.97 1.6
dTypeMDS 1.61 1.26 2.1 1.36 1.04 1.8 1.45 1.07 1.9
sexP 0.89 0.79 1.0 NA NA NA NA NA NA
Variance of frailties:
theta LL UL
6.7 6.1 7.3
Baseline hazard function components:
h1-PM LL UL h2-PM LL UL h3-PM LL UL
mu -5.60 -6.003 -5 -5.2 -9.6 -2.3 -6.75 -7.048 -6.5
sigmaSq 0.21 0.027 2 7.2 2.5 24.3 0.13 0.018 2.4
K 11.00 5.000 17 15.0 11.0 21.0 10.00 4.000 17.0
Here we provide estimates of all model parameters with their respective 95% credible inter-
vals.
6.2.2 Independent AFT model with log-Normal baseline survival distribution
Our last example is based on AFT models (1)-(3) adopting a semi-Markov assumption for h3 and
the parametric log-Normal specification for baseline survival distributions. Here we apply the
Bayesian framework via function BayesID AFT. As pointed out in Section 5.4, Formula argument
for AFT models takes a specific form:
R> simCIBMTR$LT <- rep(0,dim(simCIBMTR)[1])
R> simCIBMTR$y1L <- simCIBMTR$y1U <- simCIBMTR[,1]
R> simCIBMTR$y1U[which(simCIBMTR[,2]==0)] <- Inf
R> simCIBMTR$y2L <- simCIBMTR$y2U <- simCIBMTR[,3]
R> simCIBMTR$y2U[which(simCIBMTR[,4]==0)] <- Inf
R> formAFT <- Formula(LT | y1L + y1U | y2L + y2U ~ dTypeALL + dTypeCML + dTypeMDS +
+ sexP | dTypeALL + dTypeCML + dTypeMDS | dTypeALL + dTypeCML + dTypeMDS)
Recall that LT represents the left-truncation time, and (y1L, y1U) and (y2L, y2U) are the
interval-censored times to the non-terminal and terminal events, respectively. Next step is to
set the initial values for model parameters through the startValues argument, but now using
the auxiliary function initiate.startValues AFT:
R> startValues <- initiate.startValues_AFT(formAFT, data=simCIBMTR,
+ model="LN", nChain=3)
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Again, we considered three Markov chains (nChain=3). Using the hyperParams argument
we specify all model hyperparameters:
R> hyperParams <- list(theta=c(0.5,0.05), LN=list(LN.ab1=c(0.5,0.05),
+ LN.ab2=c(0.5,0.05), LN.ab3=c(0.5,0.05)))
Each pair of hyperparameters defines shape and scale of an inverse Gamma prior distribution
(see Section 4.1). Similar to the previous example, we must specify overall run, storage, and
tuning parameters for specific updates through the mcmcParams argument:
R> mcmcParams <- list(run=list(numReps=5e6, thin=1e3, burninPerc=0.5),
+ storage=list(nGam_save=0, nY1_save=0, nY2_save=0, nY1.NA_save=0),
+ tuning=list(betag.prop.var=rep(0.01,3), mug.prop.var=rep(0.01,3),
+ zetag.prop.var=rep(0.01,3), gamma.prop.var=0.01))
Analogous to the previous Bayesian model, a large number of scans are also required here
to achieve the convergence of the Markov chains. Again, for a quickly reproducible example,
the code for the AFT model with simplified MCMC setting is provided in Appendix C. For
more details of each item of mcmcParams, see Section 5.4. Finally, we fit the AFT model using
the function BayesID AFT and analyze the convergence of each parameter through the function
print:
R> fitBayesAFT <- BayesID_AFT(formAFT, data=simCIBMTR, model="LN",
+ startValues=startValues, hyperParams=hyperParams, mcmcParams=mcmcParams)
R> print(fitBayesAFT, digits=2)
Analysis of independent semi-competing risks data
Number of chains: 3
Number of scans: 5e+06
Thinning: 1000
Percentage of burnin: 50%
######
Potential Scale Reduction Factor
Variance of frailties, theta:
1
Regression coefficients:
beta1 beta2 beta3
dTypeALL 1 1 1
dTypeCML 1 1 1
dTypeMDS 1 1 1
sexP 1 NA NA
Baseline survival function components:
g=1 g=2 g=3
mu 1 1.1 1
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sigmaSq 1 1.0 1
...
Again, the PSRF for each parameter indicates the convergence. As a last step, we visualize
the estimate of each parameter and their respective 95% credible intervals through the function
summary:
R> summary(fitBayesAFT)
Analysis of independent semi-competing risks data
#####
Acceleration factors:
exp(beta1) LL UL exp(beta2) LL UL exp(beta3) LL UL
dTypeALL 0.68 0.55 0.85 0.95 0.86 1.0 1.09 0.86 1.4
dTypeCML 0.53 0.42 0.67 1.27 1.11 1.4 0.91 0.71 1.2
dTypeMDS 0.58 0.44 0.76 0.89 0.78 1.0 0.78 0.59 1.0
sexP 1.16 0.99 1.36 NA NA NA NA NA NA
Variance of frailties:
theta LL UL
2.6 2.5 2.8
Baseline survival function components:
g=1: PM LL UL g=2: PM LL UL g=3: PM LL UL
log-Normal: mu 8.2 8.0 8.4 6.274 6.226 6.323 6.5 6.4 6.7
log-Normal: sigmaSq 7.1 6.4 8.0 0.014 0.006 0.038 1.7 1.5 2.0
7 Discussion
This paper discusses the implementation of a comprehensive R package SemiCompRisks for
the analyses of independent/cluster-correlated semi-competing risks data. The package allows
to fit parametric or semi-parametric models based on either accelerated failure time or propor-
tional hazards regression approach. It is also flexible in that one can adopt either a Markov or
semi-Markov specification for terminal event following non-terminal event. The estimation and
inference are mostly based on the Bayesian paradigm, but parametric PHR models can also be
fitted using the maximum likelihood estimation. Users can easily obtain numerical and graphical
presentation of model fits using R methods, as illustrated in the stem cell transplantation exam-
ple in Section 6. In addition, the package provides functions for performing univariate survival
analysis. We would also like to emphasize that the vignette documentation (Lee et al., 2017b)
provides a list of detailed examples applying each of the implemented models in the package.
SemiCompRisks provides researchers with valid and practical analysis tools for semi-
competing risks data. The application examples in this paper were run using version v3.0 of the
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package, available from the CRAN at https://cran.r-project.org/package=SemiCompRisks.
We plan to constantly update the package to incorporate more functionality and flexibility to
the models for semi-competing risks analysis.
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A Simulation algorithm for semi-competing risks data
The SemiCompRisks package contains a function, simID, for simulating independent or cluster-
correlated semi-competing risks data. In this section, we provide the details on the simulation
algorithm used in simID for generating cluster-correlated semi-competing risks data based on a
parametric Weibull-MVN semi-Markov illness-death model, as presented in Section 4.3, where
the baseline hazard functions are defined as h0g(t) = αg κg t
αg−1, for g ∈ {1, 2, 3}. The step by
step algorithm is given as follows:
1. Generate Vj = (Vj1, Vj2, Vj3)
> from a MVN(0, ΣV ), for j = 1, . . . , J .
2. For each j, repeat the following steps for i = 1, . . . , nj .
a) Generate γji from a Gamma(θ
−1, θ−1).
b) Calculate ηjig = log(γji) + x
>
jigβg + Vjg, for g ∈ {1, 2, 3}.
c) Generate t∗1 from a Weibull(α1, κ1 eηji1) and t∗2 from a Weibull(α2, κ2 eηji2).
• If t∗1 ≤ t∗2, generate t∗ from a Weibull(α3, κ3 eηji3) and set tji1 = t∗1, tji2 = t∗1 + t∗.
• Otherwise, set tji1 =∞, tji2 = t∗2.
d) Generate a censoring time cji from Uniform(cL, cU ).
e) Set the observed outcome information (time1, time2, event1, event2) as follows:
• (tji1, tji2, 1, 1), if tji1 < tji2 < cji.
• (tji1, cji, 1, 0), if tji1 < cji < tji2.
• (tji2, tji2, 0, 1), if tji1 =∞ and tji2 < cji.
• (cji, cji, 0, 0), if tji1 > cji and tji2 > cji.
We note that the function simID is flexible in that one can set the θ argument as zero
(theta.true=0) to simulate the data under the model without the subject-specific shared frailty
term (γji), which is analogous to the model proposed by Liquet et al. (2012). One can gener-
ate independent semi-competing risks data outlined in Section 4.2 by setting the id and ΣV
arguments as nulls (cluster=NULL and SimgaV.true=NULL).
B Simulating outcomes using CIBMTR covariates
The true values of model parameters are set to estimates obtained by fitting a semi-Markov
Weibull PHR model to the original CIBMTR data.
R> data(CIBMTR_Params)
R> beta1.true <- CIBMTR_Params$beta1.true
R> beta2.true <- CIBMTR_Params$beta2.true
R> beta3.true <- CIBMTR_Params$beta3.true
R> alpha1.true <- CIBMTR_Params$alpha1.true
R> alpha2.true <- CIBMTR_Params$alpha2.true
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R> alpha3.true <- CIBMTR_Params$alpha3.true
R> kappa1.true <- CIBMTR_Params$kappa1.true
R> kappa2.true <- CIBMTR_Params$kappa2.true
R> kappa3.true <- CIBMTR_Params$kappa3.true
R> theta.true <- CIBMTR_Params$theta.true
R> cens <- c(365, 365)
The next step is to define the covariates matrices and then simulate outcomes using the
simID function, available in the SemiCompRisks package.
R> data(CIBMTR)
# Sex (M: reference category)
R> CIBMTR$sexP <- as.numeric(CIBMTR$sexP)-1
# Age (LessThan10: reference category)
R> CIBMTR$ageP20to29 <- as.numeric(CIBMTR$ageP=="20to29")
R> CIBMTR$ageP30to39 <- as.numeric(CIBMTR$ageP=="30to39")
R> CIBMTR$ageP40to49 <- as.numeric(CIBMTR$ageP=="40to49")
R> CIBMTR$ageP50to59 <- as.numeric(CIBMTR$ageP=="50to59")
R> CIBMTR$ageP60plus <- as.numeric(CIBMTR$ageP=="60plus")
# Disease type (AML: reference category)
R> CIBMTR$dTypeALL <- as.numeric(CIBMTR$dType=="ALL")
R> CIBMTR$dTypeCML <- as.numeric(CIBMTR$dType=="CML")
R> CIBMTR$dTypeMDS <- as.numeric(CIBMTR$dType=="MDS")
# Disease status (Early: reference category)
R> CIBMTR$dStatusInt <- as.numeric(CIBMTR$dStatus=="Int")
R> CIBMTR$dStatusAdv <- as.numeric(CIBMTR$dStatus=="Adv")
# HLA compatibility (HLA_Id_Sib: reference category)
R> CIBMTR$donorGrp8_8 <- as.numeric(CIBMTR$donorGrp=="8_8")
R> CIBMTR$donorGrp7_8 <- as.numeric(CIBMTR$donorGrp=="7_8")
# Covariate matrix
R> x1 <- CIBMTR[,c("sexP", "ageP20to29", "ageP30to39", "ageP40to49",
+ "ageP50to59", "ageP60plus", "dTypeALL", "dTypeCML", "dTypeMDS",
+ "dStatusInt", "dStatusAdv", "donorGrp8_8", "donorGrp7_8")]
R> x2 <- CIBMTR[,c("sexP", "ageP20to29", "ageP30to39", "ageP40to49",
+ "ageP50to59", "ageP60plus", "dTypeALL", "dTypeCML", "dTypeMDS",
+ "dStatusInt", "dStatusAdv", "donorGrp8_8", "donorGrp7_8")]
R> x3 <- CIBMTR[,c("sexP", "ageP20to29", "ageP30to39", "ageP40to49",
+ "ageP50to59", "ageP60plus", "dTypeALL", "dTypeCML", "dTypeMDS",
+ "dStatusInt", "dStatusAdv", "donorGrp8_8", "donorGrp7_8")]
R> set.seed(1405)
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R> simOutcomes <- simID(id=NULL, x1=x1, x2=x2, x3=x3,
+ beta1.true, beta2.true, beta3.true, alpha1.true, alpha2.true, alpha3.true,
+ kappa1.true, kappa2.true, kappa3.true, theta.true, SigmaV.true=NULL, cens)
R> names(simOutcomes) <- c("time1", "event1", "time2", "event2")
R> simCIBMTR <- cbind(simOutcomes, CIBMTR[,c("sexP", "ageP20to29", "ageP30to39",
+ "ageP40to49", "ageP50to59", "ageP60plus", "dTypeALL", "dTypeCML", "dTypeMDS",
+ "dStatusInt", "dStatusAdv", "donorGrp8_8", "donorGrp7_8")])
C Code for illustrative Bayesian examples
In order to encourage the reproducibility of the results obtained through our R package in a
reasonable computational time, Bayesian analyses contained in Section 6.2 are illustrated below
using a reduced number of scans (numReps) and extent of thinning (thin). Given the complexity
of these Bayesian models, the reduction of scans/thinning results in non-convergence of the
Markov chains, but at least it is possible to reproduce the results quickly.
C.1 Independent semi-Markov PHR model with PEM baseline hazards
R> form <- Formula(time1 + event1 | time2 + event2 ~ dTypeALL + dTypeCML +
+ dTypeMDS + sexP | dTypeALL + dTypeCML + dTypeMDS | dTypeALL +
+ dTypeCML + dTypeMDS)
R> startValues <- initiate.startValues_HReg(form, data=simCIBMTR,
+ model=c("semi-Markov","PEM"), nChain=3)
R> hyperParams <- list(theta=c(0.5,0.05), PEM=list(PEM.ab1=c(0.5,0.05),
+ PEM.ab2=c(0.5,0.05), PEM.ab3=c(0.5,0.05), PEM.alpha1=10,
+ PEM.alpha2=10, PEM.alpha3=10))
R> sg_max <- c(max(simCIBMTR$time1[simCIBMTR$event1==1]),
+ max(simCIBMTR$time2[simCIBMTR$event1==0 & simCIBMTR$event2==1]),
+ max(simCIBMTR$time2[simCIBMTR$event1==1 & simCIBMTR$event2==1]))
R> mcmcParams <- list(run=list(numReps=5e4, thin=5e1, burninPerc=0.5),
+ storage=list(nGam_save=0, storeV=rep(FALSE,3)),
+ tuning=list(mhProp_theta_var=0.05, Cg=rep(0.2,3), delPertg=rep(0.5,3),
+ rj.scheme=1, Kg_max=rep(50,3), sg_max=sg_max, time_lambda1=seq(1,sg_max[1],1),
+ time_lambda2=seq(1,sg_max[2],1), time_lambda3=seq(1,sg_max[3],1)))
R> fitBayesPHR <- BayesID_HReg(form, data=simCIBMTR, model=c("semi-Markov","PEM"),
+ startValues=startValues, hyperParams=hyperParams, mcmcParams=mcmcParams)
R> print(fitBayesPHR, digits=2)
Analysis of independent semi-competing risks data
semi-Markov assumption for h3
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Number of chains: 3
Number of scans: 50000
Thinning: 50
Percentage of burnin: 50%
######
Potential Scale Reduction Factor
Variance of frailties, theta:
3.4
Regression coefficients:
beta1 beta2 beta3
dTypeALL 1.8 1.6 1.8
dTypeCML 1.9 1.8 2.1
dTypeMDS 1.8 2.0 2.0
sexP 1.1 NA NA
Baseline hazard function components:
lambda1: summary statistics
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.1 2.9 3.2 3.2 3.6 4.3
lambda2: summary statistics
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.0 3.3 4.0 3.7 4.5 5.8
lambda3: summary statistics
Min. 1st Qu. Median Mean 3rd Qu. Max.
1.8 2.2 2.5 2.5 2.7 3.2
h1 h2 h3
mu 1.3 2.2 1.5
sigmaSq 1.0 1.1 1.0
K 1.1 1.0 1.0
######
Estimates
Variance of frailties, theta:
Estimate SD LL UL
10 0.8 9.4 12
Regression coefficients:
Estimate SD LL UL
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dTypeALL 0.10 0.19 0.82 1.59
dTypeCML 0.31 0.21 0.95 2.09
dTypeMDS 0.19 0.20 0.89 1.83
sexP -0.14 0.06 0.79 0.99
dTypeALL -0.03 0.21 0.69 1.41
dTypeCML -0.52 0.25 0.40 0.99
dTypeMDS -0.04 0.21 0.69 1.48
dTypeALL -0.34 0.24 0.47 1.13
dTypeCML 0.00 0.23 0.67 1.56
dTypeMDS 0.15 0.26 0.71 1.82
C.2 Independent AFT model with log-Normal baseline survival distribution
R> simCIBMTR$LT <- rep(0,dim(simCIBMTR)[1])
R> simCIBMTR$y1L <- simCIBMTR$y1U <- simCIBMTR[,1]
R> simCIBMTR$y1U[which(simCIBMTR[,2]==0)] <- Inf
R> simCIBMTR$y2L <- simCIBMTR$y2U <- simCIBMTR[,3]
R> simCIBMTR$y2U[which(simCIBMTR[,4]==0)] <- Inf
R> formAFT <- Formula(LT | y1L + y1U | y2L + y2U ~ dTypeALL + dTypeCML + dTypeMDS +
+ sexP | dTypeALL + dTypeCML + dTypeMDS | dTypeALL + dTypeCML + dTypeMDS)
R> startValues <- initiate.startValues_AFT(formAFT, data=simCIBMTR,
+ model="LN", nChain=3)
R> hyperParams <- list(theta=c(0.5,0.05), LN=list(LN.ab1=c(0.5,0.05),
+ LN.ab2=c(0.5,0.05), LN.ab3=c(0.5,0.05)))
R> mcmcParams <- list(run=list(numReps=5e4, thin=5e1, burninPerc=0.5),
+ storage=list(nGam_save=0, nY1_save=0, nY2_save=0, nY1.NA_save=0),
+ tuning=list(betag.prop.var=rep(0.01,3), mug.prop.var=rep(0.01,3),
+ zetag.prop.var=rep(0.01,3), gamma.prop.var=0.01))
R> fitBayesAFT <- BayesID_AFT(formAFT, data=simCIBMTR, model="LN",
+ startValues=startValues, hyperParams=hyperParams, mcmcParams=mcmcParams)
R> print(fitBayesAFT, digits=2)
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Number of chains: 3
Number of scans: 50000
Thinning: 50
Percentage of burnin: 50%
######
Potential Scale Reduction Factor
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Variance of frailties, theta:
1.7
Regression coefficients:
beta1 beta2 beta3
dTypeALL 1 1.1 1.1
dTypeCML 1 1.0 1.0
dTypeMDS 1 1.1 1.0
sexP 1 NA NA
Baseline survival function components:
g=1 g=2 g=3
mu 1.2 1.1 1.1
sigmaSq 1.4 1.7 1.2
######
Estimates
Variance of frailties, theta:
Estimate SD LL UL
1.7 0.16 1.4 2
Regression coefficients:
Estimate SD LL UL
dTypeALL -0.42 0.13 0.52 0.83
dTypeCML -0.73 0.13 0.37 0.62
dTypeMDS -0.60 0.14 0.42 0.72
sexP 0.14 0.09 0.95 1.37
dTypeALL -0.02 0.06 0.87 1.09
dTypeCML 0.30 0.06 1.20 1.54
dTypeMDS -0.10 0.07 0.78 1.01
dTypeALL 0.04 0.13 0.81 1.31
dTypeCML -0.14 0.12 0.67 1.10
dTypeMDS -0.23 0.14 0.61 1.03
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